Metabolomics

Metabolomics

Global Metabolomics Market to Reach US$9.0 Billion by 2030

The global market for Metabolomics estimated at US$3.5 Billion in the year 2023, is expected to reach US$9.0 Billion by 2030, growing at a CAGR of 14.4% over the analysis period 2023-2030. Biomarker Discovery Application, one of the segments analyzed in the report, is expected to record a 16.0% CAGR and reach US$3.6 Billion by the end of the analysis period. Growth in the Drug Discovery Application segment is estimated at 14.2% CAGR over the analysis period.

The U.S. Market is Estimated at US$965.8 Million While China is Forecast to Grow at 13.6% CAGR

The Metabolomics market in the U.S. is estimated at US$965.8 Million in the year 2023. China, the world`s second largest economy, is forecast to reach a projected market size of US$1.4 Billion by the year 2030 trailing a CAGR of 13.6% over the analysis period 2023-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 12.9% and 12.1% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 10.3% CAGR.

Global Metabolomics Market - Key Trends and Drivers Summarized

Metabolomics is emerging as a key player in fields ranging from pharmaceuticals to agriculture, defined by its comprehensive analysis of metabolites in biological specimens. This technology is integral to the development of personalized medicine, enabling a deeper understanding of metabolic processes and their direct impacts on health and disease. By analyzing metabolic profiles, metabolomics facilitates the creation of personalized treatment strategies, significantly advancing precision medicine. It plays a critical role in diagnosing diseases, understanding metabolic pathways, and crafting targeted treatments, which altogether enhance disease diagnosis and treatment customization. As metabolomics continues to be integrated more deeply into clinical practice, it promises to substantially improve personalized care approaches, offering new insights into disease mechanisms and metabolic indicators that could revolutionize healthcare and agricultural practices alike.

In practical applications, metabolomics is invaluable for its non-invasive technique to analyze biological samples, which is crucial for discovering biomarkers and ensuring drug safety across various sectors. In agriculture, it is used to enhance crop protection and test responses to environmental stresses, such as pesticides and pathogens, ensuring food safety and quality. The field has evolved from analyzing a few metabolites to now encompassing hundreds to thousands, thanks to advancements in technology that allow for a detailed characterization of metabolic phenotypes. This capability supports the precision medicine approach by identifying metabolic abnormalities, discovering therapeutic targets, and pinpointing disease biomarkers. Technologies like PET scans and magnetic resonance using hyperpolarized 13C have become instrumental in studying diseases by providing insights into metabolic changes, thereby facilitating the development of targeted therapies.

The expansion of metabolomics is driven by several key factors, including advancements in analytical and diagnostic technologies that allow for precise implant placements and the development of materials like zirconia as alternatives to traditional substances like titanium, offering new options for patients. The integration of digital dentistry through CAD/CAM technologies has streamlined implant design and fabrication processes, reducing turnaround times and enhancing customization. Increased consumer awareness and preferences for durable and aesthetically pleasing solutions such as implants, alongside the growing acceptance of cosmetic dentistry, have significantly contributed to the market demand. Improved insurance coverage and financing options have made these advanced treatments more accessible, broadening the patient base. Additionally, the global rise in the aging population who may require dental restorations further propels the demand for dental implants, ensuring ongoing market growth and innovation.

Select Competitors (Total 31 Featured) -

• AB Sciex LLC
• African Biosciences Ltd
• Agilent Technologies, Inc.
• Agios Pharmaceuticals, Inc.
• Berg LLC
• BioCat GmbH
• Biocenter Finland
• Biocrates Life Sciences AG
• Biogenetics
• Bio-Rad Laboratories, Inc.

Please note: Reports are sold as single-site single-user licenses. Electronic versions require 24-48 hours as each copy is customized to the client with digital controls and custom watermarks. The Publisher uses digital controls protecting against copying and printing is restricted to one full copy to be used at the same location.

The latest version of Adobe Acrobat Reader is required to view the report. Upon ordering an electronic version, the Publisher will provide a link to download the purchased report.

Prior to fulfillment of an order, the client will be required to sign a document detailing the purchase terms for a publication from this publisher.